2‐Methyl‐5‐[(3‐phenyl‐1,2,4‐oxadiazol‐5‐yl)methylsulfanyl]‐1,3,4‐thiadiazole

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-5368|63|10|o4180-o4180

ISSN： 1600-5368

Source： Acta Crystallographica Section E, Vol.63, Iss.10, 2007-10, pp. : o4180-o4180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2‐Methyl‐5‐{[3‐(4‐methylphenyl)‐1,2,4‐oxadiazol‐5‐yl]methylsulfanyl}‐1,3,4‐thiadiazole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4934-o4934

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐Methyl‐5‐[3‐(2‐methylphenyl)‐1,2,4‐oxadiazol‐5‐ylmethylsulfanyl]‐1,3,4‐thiadiazole

By  

Acta Crystallographica Section E, Vol. 63, Iss. 12, 2007-12 ,pp. : o4586-o4586

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐[3‐(4‐Methyl­phenyl)‐1,2,4‐oxadiazol‐5‐yl]phenol

By  

Acta Crystallographica Section E, Vol. 62, Iss. 12, 2006-12 ,pp. : o5840-o5841

John Wiley & Sons Inc

Access to resources Recommend Favorite

Meth­yl 2‐{[3‐(2‐meth­ylphen­yl)‐1,2,4‐oxadiazol‐5‐yl]meth­oxy}phenyl­acetate

By  

Acta Crystallographica Section E, Vol. 61, Iss. 5, 2005-05 ,pp. : o1390-o1392

John Wiley & Sons Inc

Access to resources Recommend Favorite

1‐{1‐[(2‐Chlorothiazol‐5‐yl)methyl]‐2‐[(2‐chlorothiazol‐5‐yl)methylsulfanyl]‐4‐methyl‐6‐phenyl‐1,6‐dihydropyrimidin‐5‐yl}ethanone

By  

Acta Crystallographica Section E, Vol. 63, Iss. 8, 2007-08 ,pp. : o3516-o3516

John Wiley & Sons Inc

Access to resources Recommend Favorite